Immunobiotics for the bovine host: their interaction with intestinal epithelial cells and their effect on antiviral immunity by Villena, Julio Cesar et al.
March 2018 | Volume 9 | Article 3261
Review
published: 02 March 2018
doi: 10.3389/fimmu.2018.00326
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Jia Sun, 
Jiangnan University, China
Reviewed by: 
Pinyi Lu, 
Biotherapeutics, Inc., 
United States  
Xu Zhang, 
The Scripps Research Institute, 
United States
*Correspondence:
Julio Villena  
jcvillena@cerela.org.ar; 
Haruki Kitazawa  
haruki.kitazawa.c7@tohoku.ac.jp
Specialty section: 
This article was submitted to 
Nutritional Immunology, 
a section of the journal 
Frontiers in Immunology
Received: 10 November 2017
Accepted: 06 February 2018
Published: 02 March 2018
Citation: 
Villena J, Aso H, Rutten VPMG, 
Takahashi H, van Eden W and 
Kitazawa H (2018) Immunobiotics for 
the Bovine Host: Their Interaction 
with Intestinal Epithelial Cells and 
Their Effect on Antiviral Immunity. 
Front. Immunol. 9:326. 
doi: 10.3389/fimmu.2018.00326
immunobiotics for the Bovine Host:
Their interaction with intestinal 
epithelial Cells and Their effect on 
Antiviral immunity
 
Julio Villena1,2,3*, Hisashi Aso4,5, Victor P. M. G. Rutten6, Hideki Takahashi7,8,  
Willem van Eden6 and Haruki Kitazawa3,5*
1 Laboratory of Immunobiotechnology, Reference Centre for Lactobacilli (CERELA-CONICET), Tucuman, Argentina, 
2 Immunobiotics Research Group, Tucuman, Argentina, 3 Food and Feed Immunology Group, Laboratory of Animal Products 
Chemistry, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan, 4 Cell Biology Laboratory, Graduate 
School of Agricultural Science, Tohoku University, Sendai, Japan, 5 Livestock Immunology Unit, International Education and 
Research Center for Food Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, 
Sendai, Japan, 6 Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 
Utrecht, Netherlands, 7 Laboratory of Plant Pathology, Graduate School of Agricultural Science, Tohoku University, Sendai, 
Japan, 8 Plant Immunology Unit, International Education and Research Center for Food Agricultural Immunology (CFAI), 
Graduate School of Agricultural Science, Tohoku University, Sendai, Japan
The scientific community has reported several cases of microbes that exhibit elevated 
rates of antibiotic resistance in different regions of the planet. Due to this emergence 
of antimicrobial resistant microorganisms, the use of antibiotics as promoters of live-
stock animals’ growth is being banned in most countries around the world. One of the 
challenges of agricultural immunology therefore is to find alternatives by modulating 
the immune system of animals in drug-independent safe food production systems. In 
this regard, in an effort to supplant antibiotics from bovine feeds, several alternatives 
were proposed including the use of immunomodulatory probiotics (immunobiotics). The 
purpose of this review is to provide an update of the status of the modulation of intestinal 
antiviral innate immunity of the bovine host by immunobiotics, and the beneficial impact of 
immunobiotics on viral infections, focused on intestinal epithelial cells (IECs). The results 
of our group, which demonstrate the capacity of immunobiotic strains to beneficially 
modulate Toll-like receptor 3-triggered immune responses in bovine IECs and improve 
the resistance to viral infections, are highlighted. This review provides comprehensive 
information on the innate immune response of bovine IECs against virus, which can be 
further investigated for the development of strategies aimed to improve defenses in the 
bovine host.
Keywords: immunobiotics, antiviral immunity, beneficial microbes, bovine rotavirus, toll-like receptor 3 pathway, 
inflammation, agricultural immunology
iNTRODUCTiON
Over the past decades, the global bovine production has been subjected to intensification, in 
order to improve efficiency of production because of the demand from a growing human popula-
tion. The intensification of bovine production involved the application of confinement methods 
characterized by the concentration of animals in large outdoor feedlots or in specialized indoor 
2Villena et al. Beneficial Microbes for Bovine
Frontiers in Immunology | www.frontiersin.org March 2018 | Volume 9 | Article 326
environments. In confinement, the potential for transfer of 
pathogens among animals is higher, as there are more animals 
in a smaller space (1–3).
Severe gastrointestinal infectious diseases causing malab-
sorption and diarrhea are important causes of discomfort and 
death in young calves, resulting in important economic losses 
to bovine producers. Gastrointestinal infectious diseases are 
able to cause significant economic losses to the cattle industry 
in big cattle-producing countries and can impair the develop-
ment of cattle industry in small cattle-producing countries 
(1–3). In particular, the neonatal gastroenteritis in the bovine 
host is a multifactorial disease. This disorder can be caused by 
different bacterial or viral pathogens, including bovine corona-
virus (BCV), bovine rotavirus (BRV), and bovine viral diarrhea 
viruses (BVDV) (4, 5). Although these viral pathogens belong 
to distinct families and possess different physical characteristics, 
they are all able to infect intestinal epithelial cells (IECs), gener-
ate villous atrophy, and cause inflammatory intestinal tissue 
damage and diarrhea.
Probiotics are defined as live microorganisms with the capac-
ity to confer a health benefit on the host when administered in 
adequate amounts. Among them, those that are able to impact 
on human and animal health by modulating the mucosal and 
systemic immune systems have been called immunobiotics. It 
has been reported that immunobiotic lactic acid bacteria are able 
to generate protection against viral pathogens by differentially 
modulating antiviral immune responses in humans and livestock 
animals like pigs (6, 7). It is also believed that immunobiotics 
could be used in cattle feeds to improve bovine health and pro-
duce safe animals (8–10).
The purpose of this review is to provide an update of the status 
of the modulation of intestinal antiviral innate immunity in the 
bovine host by immunobiotics, and their beneficial impact on 
viral infections. The results of our group, which demonstrate the 
capacity of immunobiotic strains to advantageously modulate 
Toll-like receptor (TLR)-3-triggered immune responses in 
bovine IECs and improve the resistance to viral infections, are 
particularly highlighted.
THe USe OF PROBiOTiCS iN THe BOviNe 
HOST
Before weaning, dairy calves are highly susceptible to infectious 
diseases. For several years, antimicrobial compounds have been 
used to reduce the severity and mortality of infectious diseases 
and to improve economic benefits in terms of enhanced bovine 
performance and diminished medication expenses. However, 
the use of antibiotics in livestock animal management is in 
question because of the enhanced resistance of microbes to 
antimicrobial compounds. Therefore, there is an urgent need to 
reduce and finally eliminate the use of antibiotics in livestock 
and for this purpose many feed additives have been proposed 
including beneficial microbes (8–10). In fact, research from the 
past decade has provided evidence that probiotic bacteria and 
prebiotics can be effectively used to improve health and growth 
in calves and reduce the use of antibiotics (Table  1), although 
detailed mechanistic studies were not performed. The production 
of antimicrobial compounds, inhibition of adherence or aggrega-
tion with pathogens and the modulation of the microbiota were 
described as mechanisms of probiotics action in the bovine host 
[reviewed in Ref. (10)]. Immunomodulation was also proposed as 
a mechanism of bovine probiotics as mentioned later.
As described for other livestock animals, the most critical stage 
in the bovine life is the period from birth to weaning. During 
this stage factors like nutrition can directly affect the immune 
system development and function and impact later in bovine 
performance (26). However, nutritional interventions during this 
phase are often inappropriate due to the elevated costs of milk 
feeding. The administration of poor-quality milk or colostrum, 
and the additions of antibiotics are common practices. Poor 
nutrition during preweaning stage often conduces to low wean-
ing weight and impaired immunity, thereby increasing losses 
related to disease. Therefore, the majority of research studying 
the influence of beneficial microbes in the bovine host has been 
performed during this period of life.
Early studies showed that orally administered Bifidobacterium 
pseudolongum M-602 or Lactobacillus acidophilus LAC-300 
enhanced the gain of body weight and reduced diarrhea frequency 
in calves (11). Similarly, several subsequent studies reported that 
treatments with probiotic microorganisms beneficially influence 
body weight gain, body height, milk production, and the general 
health condition of calves (Table 1). Additionally, oral treatment 
with probiotics significantly reduced the incidence and the sever-
ity of gastrointestinal infections. Moreover, some studies have 
also shown that probiotic treatments are able to improve not only 
mucosal defenses in the bovine host but systemic immunity as 
well (20, 21).
Classical probiotic strains have been used to evaluate their 
beneficial effects on the bovine hosts including Lactobacillus, 
Bifidobacterium, Enterococcus, Bacillus, and the yeast 
Saccharomyces (Table 1). More recently, new species of beneficial 
bacteria have been also tested as next-generation probiotics. In 
this regard, the obligate anaerobic, Gram-positive microorgan-
ism Faecalibacterium prausnitzii that belongs to the phylum 
Firmicutes has been tested as a potential probiotic for the bovine 
host (27). Oikonomou et al. (27) reported that the high relative 
abundance of this bacterium in the first week of life of Holstein 
calves was associated with improved weight gain and diminished 
occurrence of diarrhea. Recently, Foditsch et al. (22) confirmed 
the safety and efficacy of F. prausnitzii in young dairy heifers. 
Researchers reported that the oral administration of viable F. 
prausnitzii reduced severe diarrhea incidence and its related 
mortality rate. Moreover, F. prausnitzii treatment significantly 
enhanced the weight gain.
The anti-inflammatory properties of F. prausnitzii, includ-
ing its ability to synthetize butyrate, were proposed as factors 
involved in the beneficial effects observed in calves. These works 
demonstrated that this intestinal bacterium could be a novel 
approach to enhance the intestinal health in calves and improve 
their body weight gain (22).
These studies indubitably show the potential of beneficial 
microbes to differentially modulate weight gain, intestinal 
hemostasis, and immunocompetence in young calves. 
TABle 1 | Probiotics for the bovine host.
Strain viability Route Host effects Reference
Lactobacillus acidophilus LAC-300 Viable Oral Holstein calves Increase in body weight gain. Improvement in fecal 
scores
(11)
Bifidobacterium pseudolongum M-602 Viable Oral Holstein calves Increase in body weight gain. Improvement in fecal 
scores
(11)
Bifidobacterium thermophilum S-501, Lactobacillus 
acidophilus LAC-300, and Enterococcus faecium  
FA-5
Viable Oral Holstein calves No effect on body weight gain was observed.  
Reduction of diarrhea
(11)
Saccharomyces cerevisiae, Lactobacillus acidophilus, 
Bifidobacterium bifidum, Streptococcus termophilus, 
and Aspergillus niger
Viable Oral Holstein calves Improvement in daily live weight gain and feed  
efficiency ratio. Reduction of diarrhea
(12)
Lactobacillus rhamnosus GG Viable Oral Holstein calves The probiotic strain survived the gastrointestinal transit. 
No beneficial effect was recorded
(13, 14)
Saccharomyces boulardii Viable Oral Holstein bull calves Treated animals consumed more grain, had 
increased weight gain, and increased plasma glucose 
concentrations. Days with diarrhea were reduced
(15)
Lactobacillus acidophilus 15 Viable Oral buffalo calve (1 day to 
31 weeks)
Weight gain was improved and feed: gain ratio was 
reduced
(16)
Multispecies probiotic preparation: Lactobacillus 
acidophilus W55, Lactobacillus salivarius W57, 
Lactobacillus paracasei W56, Lactobacillus  
plantarum W59, Lactococcus lactis W58, and 
Enterococcus faecium W54
Viable Oral Male Holstein-Friesian 
calves
Probiotics enhanced growth rate and average daily  
gain and feed efficiency were significantly improved. 
Modest effect on diarrhea
(17)
Calf-specific multistrain probiotic preparation  
(six lactobacilli strains)
Viable Oral Male Holstein-Friesian 
calves
Probiotics enhanced growth rate and average daily 
gain and feed efficiency were significantly improved. 
Treatment reduced the incidence of diarrhea and the 
fecal counts of coliforms
(17)
Lactobacillus casei subsp. casei JCM1134T and 
Dextran
Viable Oral Holstein dairy calves Increase the milk production (18)
Lactobacillus acidophillus, Bifidobacterium bifidum, 
and Enterococcus faecium
Viable Oral Holstein calves Significant reduction of diarrhea but no effect  
on mastitis
(19)
Bacillus subtilis natto Viable Oral Male Holstein calves Increased average daily gain and feed efficiency. No 
difference in serum IgE, IgA, and IgM, whereas serum 
IgG and IFN-γ were higher in probiotic-treated than in 
the controls.
(20)
Lactobacillus plantarum 220, Enterococcus faecium 
26, and Clostridium butyricum Miyari
Viable Oral Holstein bull calves Increased the numbers of CD282+ monocytes, CD3+ 
T cells and CD4+, CD8+, and WC1+ γδ T cell in blood. 
Increment of production of IL-6, INF-γ, and TNF-α were 
also observed
(21)
Faecalibacterium prausnitzii 34, Faecalibacterium 
prausnitzii 35, Faecalibacterium prausnitzii 1S, and 
Faecalibacterium prausnitzii 2S
Viable Oral Preweaned dairy 
Holstein heifer calves
Decreased the incidence of severe diarrhea and related 
mortality rate, while increasing weight gain
(22)
Lactobacillus plantarum GF103 Viable Oral Male Holstein calves No significant differences were observed in dry matter 
intake or average daily gain, but the feed conversation 
ratio was improved. Treatment improved mitogen-
induced lymphocyte proliferation
(23)
Kefir Viable Oral Female Holstein calves 
calves
Kefir intake improved fecal scores and reduced days 
with diarrhea during the first 2 weeks of life.  
No effect on weight gain
(24)
Milk fortified with symbiotic complex containing 
prebiotics (mannan-oligossacharides) and probiotics 
(Lactobacillus acidophilus, Enterococcus faecium, 
Bacillus subtilis, Saccharomyces cerevisiae)
Viable Oral Female Holstein heifer 
calves
Symbiotic did not affect weight gain or feed efficiency  
of calves but it improved fecal scores
(25)
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However, the cellular and molecular interactions of probiot-
ics with the cells of the bovine host have not been studied in 
depth. A better molecular understanding of how the selected 
beneficial microbes improve resistance against infections 
by antagonizing pathogens and/or modulating the immune 
system is needed.
4Villena et al. Beneficial Microbes for Bovine
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BOviNe ieCs AS A MODel TO STUDY 
ANTiviRAl iMMUNiTY
It is considered that an important step forward toward the under-
standing of the cellular and molecular interactions of pathogenic 
or probiotic microorganisms with the bovine host is the estab-
lishment of appropriate in vitro systems models. Therefore, the 
development of suitable bovine cell cultures such as IECs would 
be of great value to advance in this field of research. Those cell 
cultures should be minutely characterized with regard to their 
permissiveness for bacterial and viral adhesion and invasion, 
and the ability to sense microbial-associated molecular patterns 
through pattern recognition receptors (PRRs) (28).
Primary cultures of small or large IECs have been used to 
evaluate the effects of microbial virulence factors, toxic com-
pounds, and antimicrobial factors in cattle. Moreover, those pri-
mary cultures have been also used for the study of innate immune 
responses through PRRs signaling (28–33). Soft mechanical 
agitation combined with enzymatic digestion using dispase and 
collagenase has been proved to successfully release viable intact 
bovine colonic cells. However, these cells suspensions contained 
contaminating non-epithelial cells (mostly fibroblasts) and there-
fore, a series of purification steps was required to obtain relatively 
pure bovine colonic cells. The development of primary bovine cell 
lines from rectum, colon and ileum was reported by Dibb-Fuller 
et al. (29). Those bovine primary cell cultures were successfully 
used to evaluate the interaction of several intestinal pathogenic 
bacteria with bovine IECs and to determine mechanisms of 
adherence and invasion. More recently, Zhan et al. (34) success-
fully cultured primary bovine IECs and established a novel clone 
cell method. Authors demonstrated the expression of E-cadherin 
and cytokeratin 18, as well as characteristics of epithelial-like 
morphology in this new cell line. However, the immunological 
characteristics of cells or viral infections have not been evaluated 
in those systems.
As mentioned earlier, viral infections in livestock animals 
could cause a fatal disease that implicate serious economic loses. 
Therefore, the effective and non-costly control of this type of 
infections is a key factor for improving animal production. It 
is believed that the clear and detailed understanding of viral 
pathogenicity as well as host immune response in the bovine host 
is necessary to develop strategies capable of reducing infectious 
disease caused by these viruses. In this sense, a deeper under-
standing of the molecular interactions of virus with bovine IECs 
is necessary for the development of better prevention strategies 
to improve protection in animals.
Bovine virus pathology and immune response have been 
studied mainly in heterologous systems including mouse models 
(35) and human cell lines (36). Taking into consideration the 
differences in viral strains, the specific receptors for virus uptake, 
the factors required for viral replication and pathogenesis as well 
as the specific species variations in innate immune responses; 
the information generated in those heterologous models may 
not be fully applicable to cattle. Therefore, scientists have tried to 
establish bovine systems for the study of viral infections. One of 
the earliest works able to confirm that cultured bovine IECs were 
susceptible to BRV infection was reported by Kaushik et al. (37). 
Epithelial cultures obtained from jejunal and ileal tissues were 
incubated with BRV and both cell types were similarly infected 
with the viral pathogen. Long incubation times of BRV with the 
epithelial cultures coming from jejunal and ileal tissues resulted 
in extensive cellular damage and reduced cell viability, which is 
in line with the knowledge that BRV is a lytic virus. Furthermore, 
BRV particles were recovered from the culture supernatants 
confirming that viral replication occurred in bovine IECs (37). 
However, the immune response was not studied. In addition, 
those epithelial cell cultures contained fibroblasts, and therefore 
if the immune response is evaluated in this system it cannot be 
discriminated whether the response (cytokine production, for 
example) is mediated by one or both cells, especially consider-
ing that the authors also demonstrated that BRV infected and 
replicated in fibroblasts (37).
Bovine primary IEC cultures have been of value to study the 
molecular mechanisms involved in diseases caused by pathogens. 
However, the cellular and molecular interactions of beneficial or 
commensal microorganisms with bovine IECs cells have been 
less examined. In addition, the intestinal cell lines established 
from adult cattle may have limitations in the study of infections 
with BRV, BVDV, or BCV, since these viruses infect IECs in the 
gut of young calves (4, 5).
In order to understand: (i) the pathogenesis of bovine viral 
infections and the subsequent gastrointestinal diseases, (ii) 
the role of bovine IECs in the generation of mucosal immune 
responses, and (iii) the effect of beneficial microbes that may be 
used to advantageously modulate the antiviral immune response 
in bovine IECs; we have developed an immortalized bovine IEC 
line from young calves: bovine intestinal epithelial (BIE) cells (38).
Bovine intestinal epithelial cells have an epithelial-like 
morphology and they grow forming a monolayer with cells that 
establish close contact between them (38). Scanning electron 
microscopy analysis revealed that 3-day-old BIE cells have micro-
villi-like structures on their surface that are irregular and slender. 
These cellular structures increase in complexity as the cells grow 
as observed in 10-day-old BIE cells (38). The evaluations of the 
expression of cytokeratin and specific villin protein, which are 
known as markers of epithelial cells, have demonstrated that BIE 
cells are strongly positive for both proteins. In contrast, vimentin 
and desmin that are markers for mesenchymal cells and muscle 
cells, respectively, were not found in BIE cells.
Bovine intestinal epithelial cells also expressed the cell-to-cell 
adhesion molecules ZO-1 and beta-catenin (39). Both proteins 
were strongly positive in the cell-to-cell contact region when 
cells reached confluence. Moreover, the functional integrity of 
BIE cells gradually increased with time as indicated by studies of 
TEER and paracellular permeability (38). These results provide 
clear evidence of the intestinal epithelial nature of BIE cells.
iMMUNOBiOlOGY OF BOviNe 
ePiTHeliAl CellS
Significant progress has been made in the understanding of both 
the beneficial and detrimental roles of TLR3 in innate antiviral 
immune responses in mucosal tissues (6, 40). Therefore, to 
decipher the exact role of TLR3 in antiviral defenses in IECs is 
5Villena et al. Beneficial Microbes for Bovine
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of value to understand the mechanisms that activate and regulate 
the intestinal immune system of the host. Few studies have been 
conducted on cattle. Those studies are of importance since the 
determination of the mechanisms involved in the activation 
and regulation of TLR3 in bovine IECs could give the scientific 
basis for the development of efficient preventive or therapeutic 
strategies for reducing severity and mortality of viral diseases, 
including oral vaccines and functional feeds. Then, the expression 
of mRNAs of TLRs was evaluated in BIE cells and it was reported 
that all the genes for these receptors were expressed in this cell 
line (41). TLR1, TLR3, TLR4, and TLR6 were strongly expressed 
while TLR5, TLR9, TLR2, and TLR7 were expressed modestly. 
We were especially interested in expression of TLR3 as the most 
important receptor detecting double-stranded genomic RNA 
(dsRNA) from viruses.
Therefore, to confirm these findings, we further examined the 
expression of TLR3 protein in BIE cells by immunohistochemical 
analysis and demonstrated that this PRRs is strongly expressed in 
the cytoplasm of BIE cells (42). Of note, no TLR3expression was 
detected at the BIE cell surface. Therefore, BIE cells, in addition to 
displaying characteristics of epithelial cells like those mentioned 
earlier such as microvilli-like structures, and strong expression of 
cell-to-cell junctional proteins (38), they also express TLR3 and 
thus are similar to the IECs of other species.
The innate immune response induced by TLR3 activation in 
BIE cells was also studied. BIE cells were treated with the TLR3 ago-
nist poly(I:C) and an upregulation of type I interferon (IFN), and 
proinflammatory cytokines expression was detected. The changes 
in the expression of inflammatory factors induced by poly(I:C) in 
BIE cells correlate with the changes reported in various intestinal 
viral infections of cattle and other hosts. For instance, enhanced 
gene expression of CCL5 (RANTES), CXCL10 (IP-10), CXCL8 
(IL-8), and CCL2 (MCP-1) were observed in rotavirus-infected 
HT-29 cells (43, 44). In addition, in vitro studies showed that the 
challenge of bovine intestinal tissues with BRV or BCV activated 
TLR3, upregulated nuclear factor κB (NF-κB) and increase IL-6 
production (4). These findings indicate that BIE cells are valuable 
tools for the in  vitro study of immune responses mediated by 
TLR3 in bovine IECs.
Bovine rotavirus is able to induce a potent inflammatory 
response mediated by IFN and IFN-induced genes as well as 
inflammatory cytokines. In this regard, studies performed in 
HT29 cells infected with BRV (A5-13 strain) demonstrated that 
viral infection significantly upregulated most of the IFN-inducible 
genes including IL-18, IFN-α-inducible protein 6, IFN-induced 
transmembrane protein 3, TAP1, DDX58 [retinoic acid induc-
ible gene-I (RIG-I)], and 2′-5′-oligoadenylate synthetase (OAS) 
1 as well as several cytokines such as IL-8, CCL5, CXCL10, and 
CXCL11 (36). Few studies evaluated the BRV infection and its 
immune responses by using in vivo or in vitro bovine systems. By 
performing an intestinal loop surgical technique, Aich et al. (4) 
investigated the innate immune responses against bovine BRV in 
newborn calves. BRV (field isolate BRV85) challenge was able to 
induce accumulation of fluid and visible histological alterations 
in the gut of infected animals. Moreover, transcriptional profile of 
gene expression analysis and qPCR revealed that BRV enhanced 
TLR3, NF-κB p65, and IL-6. In addition, IRF1, a transcriptional 
regulator involved in the activation of IFN responses, was acti-
vated after rotaviral challenge (4).
We demonstrated that 10-days old BIE cells have developed 
microvilli-like structures on their surface (45). These charac-
teristics of BIE cells together with their capacity to respond to 
TLR3 activation allowed us to hypothesize that this cell line 
could be a valuable in  vitro tool for studying the interactions 
between BRV and bovine IECs. Therefore, we compared the 
infection capacity of four rotavirus strains in BIE cells including 
human (Wa), murine (EW), porcine (OSU), and bovine (UK), 
and we found that BIE cells can be effectively infected with the 
four rotavirus strains (45). Our results showed that 3-day-old 
BIE cells were more resistant to rotavirus infection than 10-day 
cultured cells, which probably related to the differences in the 
length and number of microvilli present on their surfaces. As we 
mentioned previously, the presence of these cellular structures 
is important for rotaviral infection since it was suggested that 
differentiated non-dividing mature enterocytes express the fac-
tors that are essential for the efficient rotavirus infection and 
replication (46, 47). In addition, we found significant differences 
regarding the viral titers when rotaviruses of different origins 
were compared. BIE cells were highly infected by bovine and 
porcine strains, whereas human and murine rotavirus showed 
a lower capacity to infect this bovine cell line (45). We also 
observed that viral titers were higher in BIE cells infected with 
UK than OSU strains, confirming that BRV strain isolated from 
cattle has a higher capacity to infect these cells. This is in line 
with previous studies that reported that the infection of porcine 
small intestinal epithelial (IPEC-J2) cells with OSU rotavirus 
induced a higher cytopathic effect and significantly reduced 
cell survival when compared with Wa strain (48). Moreover, 
our results in BIE cells are also in agreement with our results in 
porcine IECs (PIE cells) that showed a higher capacity of OSU 
rotavirus to infect those cells when compared to UK, Wa, or EW 
strains (49).
The innate immune response triggered by BRV infection in 
BIE cells was also characterized (Figure  1). We observed that 
BRV challenge activated antiviral PRRs in BIE cells and induced 
immune responses characterized by IFN regulatory factor-3 
(IRF3) and NF-κB activation, with the subsequent upregulation 
of IFN-β and inflammatory chemokines and cytokines. Those 
results are in agreement with the innate immune mechanisms 
described for BRV infection in several experimental models as 
mentioned previously (4, 35, 36). Of interest, we also observed 
that UK rotavirus was able to induce a stronger innate immune 
response in BIE cells than OSU strain as demonstrated by the 
higher levels of expression of inflammatory factors IL-6, IL-8, 
MCP-1, and IFN-β.
The, BIE cells have several characteristics that make them 
extremely interesting for the study of BRV pathogenesis, and 
the molecular mechanisms involved in the generation of 
innate immune responses. In addition, this cell line could be 
of value for the evaluation of treatments aimed to beneficially 
modulate antiviral defenses and reduce inflammatory-mediated 
damage.
FiGURe 1 | Antiviral Innate immune response against rotavirus in bovine intestinal epithelial (BIE) cells. Rotavirus double-stranded genomic RNA activates toll-like 
receptor 3 (TLR3), retinoic acid inducible gene-I (RIG-I), and melanoma differentiation-associated gene-5 (MDA-5), which are pattern recognition receptors (PRRs) 
expressed in BIE cells. Cellular signaling cascades are activated and converge at the level of interferon (IFN) regulatory factor-3 (IRF3) that upregulate the expression 
of type I (IFN-α, IFN-β) and type III (IFNλ1, IFNλ2/3) IFN, which in turn induces the synthesis of IFN-stimulated genes with antiviral activities including: myxovirus 
resistance 1 IFN-inducible protein (Mx1), MxA, ribonuclease L (RNaseL), 2′-5′-oligoadenylate synthetase (OAS), and protein kinase R (PKR). Antiviral PRRs also 
activate nuclear factor κB (NF-κB) pathway and induce the secretion of proinflammatory cytokines and chemokines including: interleukin 6 (IL-6), IL-8, monocyte 
chemotactic protein 1 (MCP-1/CCL2), and IFN gamma-induced protein 10 (IP-10/CXCL10).
6
Villena et al. Beneficial Microbes for Bovine
Frontiers in Immunology | www.frontiersin.org March 2018 | Volume 9 | Article 326
BOviNe ieCs AS A MODel TO SeleCT 
AND CHARACTeRiZe iMMUNOBiOTiCS 
wiTH ANTiviRAl ACTiviTY
The capacity of beneficial microbes to differentially modulate the 
response of BIE cells to TLR3 stimulation was evaluated by using 
several lactobacilli and bifidobacteria strains (42, 45) (Figure 2). 
Some strains such as L. rhamnosus LA-2, S. thermophilus 
TMC1543 (42), B. infantis MCC12, and B. breve MCC1274 (45) 
were able to enhance IFN-β levels after poly(I:C) challenge. The 
improved production of IFN-β by BIE cells after TLR3 activa-
tion induced by those probiotic strains may have significant 
in vivo effects in the protection against enteric viruses. It is well 
known that IFN-α and IFN-β are important factors of the innate 
immune response against viral infections. Type I IFNs, after their 
interaction with the IFN-α/β receptor (IFNAR), upregulate the 
expression of hundred of antiviral proteins capable to reduce 
or inhibit viral replication and promote viral clearance. In this 
regard, transcriptomic analyses of bovine intestinal tissues after 
the challenge with BRV or BCV have shown that the expression 
of several IFN-regulated genes is reduced, supporting the conclu-
sion that both viruses have developed mechanism(s) to inhibit 
immune responses mediated by IFNs (4). Moreover, it has been 
reported that BVDV is able to impair the induction of type I IFN, 
which not only affect innate immunity, but in addition interferes 
with the appropriate development of adaptive immune defenses 
(5, 50). Based on these findings, immunobiotics that enhance 
IFN-β production in BIE cells could have a prominent role in the 
reinforcement of innate and adaptive immune responses against 
bovine intestinal virus.
As the duration and intensity of proinflammatory factors secre-
tion after TLR3 activation by viral dsRNA can become harmful to the 
host (51), we also evaluated the levels of key inflammatory cytokines 
and chemokines in BIE cells including IL-6, IL-8, and MCP-1. Our 
results indicated that BIE cells pretreated with the probiotic strain L. 
casei TMC0409 (42) produced lower levels of MCP-1, IL-6, and IL-8 
when compared with control cells after stimulation with poly(I:C). 
It has been well established that the unregulated activation of 
TLR3 is capable to mediate detrimental inflammatory responses 
in the intestine, thus contributing to the tissue damage induced by 
viral infections (6, 52). Therefore, the diminished production of 
proinflammatory factors after the exposure to immunobiotics may 
allow a better control of the inflammatory responses and reduce the 
tissue injury mediated by this mechanism. In this way, beneficial 
bacteria like the TMC0409 strain may offer a different protection 
mechanism against bovine viral infection.
FiGURe 2 | Beneficial effects of immunobiotics on the antiviral innate immune response against rotavirus in bovine intestinal epithelial (BIE) cells. Rotavirus 
doublestranded genomic RNA activates toll-like receptor 3 (TLR3), retinoic acid inducible gene-I (RIG-I), and melanoma differentiation-associated gene-5 (MDA-5), 
which are pattern recognition receptors (PRRs) expressed in IECs. Cellular signaling cascades mediated by interferon (IFN) regulatory factor-3 (IRF3) upregulate the 
expression of type I (IFN-α, IFN-β), and type III (IFNλ1, IFNλ2/3) IFN, which in turn induces the synthesis of IFN-stimulated genes with antiviral activities including: 
myxovirus resistance 1 IFN-inducible protein (Mx1), MxA, ribonuclease L (RNaseL), 2′-5′-oligoadenylate synthetase (OAS), and protein kinase R (PKR). Antiviral 
PRRs also activate nuclear factor κB (NF-κB) pathway and induce the secretion of proinflammatory cytokines and chemokines including: interleukin 6 (IL-6), IL-8, 
monocyte chemotactic protein 1 (MCP-1/CCL2), and IFN gamma-induced protein 10 (IP-10/CXCL10). Preventive treatment of BIE cells with immunobiotics increase 
the activation of IRF3, improve the production of the antiviral factors and differentially regulate the expression of inflammatory mediators.
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In conclusion, the BIE cells in vitro system was of value for the 
efficient screening of two types of immunomodulatory probiotic 
strains capable to improve protection against viral intestinal 
diseases in the bovine host: (i) strains with the ability to increase 
antiviral defenses like L. rhamnosus LA-2, B. infantis MCC12 
and B. breve MCC1274 and (ii) strains with anti-inflammatory 
capacities like L. casei TMC0409.
Considering the mentioned results and that some recent 
research indicated that the presence of bifidobacteria in the gut 
of young calf is associated with a good health status (53), we next 
aimed to evaluate the capacity of the selected immunobiotic 
bifidobacteria strains to improve resistance of BIE cells to viral 
challenge.
Studies with the porcine IPEC-J2 cell line, demonstrated that 
L. rhamnosus GG reduced the mucin and IL-6 secretion response 
triggered by porcine rotavirus, diminishing the inflammatory 
damage (48). Our own studies in PIE cells also demonstrated 
that selected immunobiotic strains were capable to upregulate 
IFN-β expression in response to poly(I:C) stimulation (54, 55). 
Moreover, we recently demonstrated that B. infantis MCC12 
and B. breve MCC1274 were capable to significantly improve 
the resistance of PIE cells to porcine rotavirus infection (49). 
Both immunobiotic bifidobacteria strains significantly enhanced 
the expression of IFN-β, MxA and ribonuclease L (RNaseL) in 
infected PIE cells, reducing viral replication. Therefore, we aimed 
to determine whether the studies performed in our laboratory 
using porcine IECs could be reproduced in BIE cells. Then, we 
evaluated whether immunobiotic B. infantis MCC12 and B. breve 
MCC1274 were able to protect BIE cells against BRV infection.
We showed that BIE cells treated with bifidobacteria were more 
resistant to BRVs infection, and that MCC12 and MCC1274 treat-
ments significantly increased IFN-β in BRV-infected BIE cells. This 
is in line with the observation that BRV replication is restricted in 
susceptible cells by preventive treatment with recombinant IFN-β 
(56). Likewise, administration of recombinant IFN-β to newborn 
calves prior to BRV challenge suppresses virus replication and 
diminishes disease severity (57). A recent study reported the 
antiviral activity of bacterial strains in mice and Caco-2 cells, in 
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which the probiotic B. longum SPM1206 and L. ruminis SPM0211 
induced the expression of IFN-β in response to human rotavirus 
(58). Moreover, these probiotic strains had the capacity to inhibit 
RVs infection through the increase IFN signaling component 
(STAT1), and IFN-inducible antiviral effectors MXA, protein 
kinase R (PKR), and OAS in mice. In line with these findings, 
our recent immunotranscriptomic analysis showed that both B. 
infantis MCC12 and B. breve MCC1274 are able to improve the 
expression of several antiviral factors through their capacity to 
improve IFN-β production. Both bifidobacteria improved the 
expression of IFN-α and IFN-β as well as the antiviral factors 
RNASEL, MX1, and MX2 when compared to controls. In addition, 
bifidobacteria increased the expression of NLRP3 [Albarracin 
et al. (59), in preparation]. In agreement with the central role of 
IFN-β in the protection of BIE cells against BRV, we also observed 
that B. breve MCC1274 induced an earlier and higher activation 
of TRAF3, higher levels of IFN-β and significantly lower titers of 
BRV in infected BIE cells when compared with B. infantis MCC12. 
The mechanism(s) (probiotic molecules and host receptors and 
signaling pathways) by which these immunobiotic bifidobacteria 
induce higher expression of IFN-β in BRV-infected BIE cells is an 
interesting topic for future research.
CONClUSiON
Prophylactic administration of low doses of antibiotics has been 
historically used to promote the growth and avoid infectious 
diseases in livestock animals. However, due to the emergence of 
antibiotic resistant microbes, several governments in countries 
around the world have prohibited the use of antibiotics as growth 
promoters for animals.
One of the most important challenges of agricultural immu-
nology therefore is to find alternatives for developing drug-
independent safe food production systems by modulating the 
immune system of animals. The work reviewed here encourages 
the research of probiotics to beneficially modulate the immune 
system of the bovine host. This review provides comprehensive 
information on the innate antiviral immune response of bovine 
IECs against virus, which can be further studied for the devel-
opment of strategies aimed to improve antiviral defenses. The 
analyzed data also suggest that beneficial microbes have a great 
potential to be used as antiviral alternatives able to reduce severity 
of infections in the bovine host.
The development of specific in vitro study systems for cattle 
such as BIE cells as well as the selection and characterization of 
microbes that exert beneficial functions specifically and efficiently 
in the bovine host are key points for the successful development 
of immunomodulatory feeds aimed to protect against infections 
and reduce or avoid the use of antibiotics.
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